Scientists have uncovered that a bitter taste receptor, TAS2R14, can respond to both extracellular and intracellular signals simultaneously. This discovery reveals that these receptors respond not just to bitter-tasting substances, but also different types of drugs. It opens new possibilities for drug design by better understanding how the receptor reacts to various medicinal compounds.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
